Recall
FDAHealthApril 2, 2026

DFI Co., Ltd. — QUCARE Total Cholesterol in vitro diagnostic test REF: 6407

⚠️ The devices were distributed without required FDA premarket clearance or approval.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
April 2, 2026

Worldwide - US Nationwide distribution in the states of FL, PA and the country of England.

What's affected?

Product
QUCARE Total Cholesterol in vitro diagnostic test REF: 6407
Lot code
BS032501

Additional details

UDI: 08806141303060/ Lot: BS032501, BS042502, BS062501, BS062502, BS082501

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 6398 units.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.